Success Stories: From Cutting-Edge Cancer Genetics to a Green Card: Another EB-2 NIW Success Story
Client’s Testimonial:
“I am extremely grateful for the professional guidance and support I received during my EB-2 NIW application. The Chen Immigration Team helped me clearly present my achievements in cancer genetics and molecular biology, making the process smooth and efficient. Thanks to their expertise, I received my approval on April 10th, 2025 (Processing Time: 10 months, 12 days). I highly recommend their services to other researchers and will refer them to my friends. ”
On April 10th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Molecular Biology (Approval Notice).
General Field: Molecular Biology
Position at the Time of Case Filing: Research Fellow
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: April 10th, 2025
Processing Time: 10 months, 12 days
Case Summary:
We are honored to support pioneering researchers whose work is not only shaping the future of science but also addressing urgent global health needs. One such client recently secured approval for an EB-2 National Interest Waiver (NIW), marking a major milestone in his journey to continue vital cancer research in the United States.
Tackling Cancer Resistance at the Genetic Level
Our client is a research fellow whose research focuses on uncovering the genetic mechanisms that cause resistance to cancer therapies. By employing state-of-the-art screening techniques, he aims to accelerate the development of next-generation combination therapies that can overcome tumor resistance—an endeavor of both substantial merit and national importance.
This area of research has immense implications. Multidrug resistance is responsible for the majority of cancer treatment failures globally, and this scientist’s work directly addresses this life-threatening problem. From exploring gene targets that affect immunotherapy response to examining the molecular behavior of oncogenic proteins, his work is pushing the boundaries of precision medicine.
A Researcher Positioned for Impact
Currently employed as a research fellow at one of the nation's leading medical research institutions, the client brings advanced training in biochemistry and molecular biology, along with a prolific academic portfolio. His research has resulted in six peer-reviewed journal articles, one preprint, and one patent application. Several of these publications appear in top-tier journals, including Signal Transduction and Targeted Therapy and the Journal of Hepatology, and are frequently cited in the field.
His work has been cited 369 times, and he has performed peer review for respected journals such as BMC Cancer and Heliyon, with at least 13 completed reviews. At least six of his publications are among the most highly cited in molecular biology and genetics for their publication years—an impressive indicator of the relevance and impact of their work.
Another Approval, Another Step Forward
USCIS approved the client's EB-2 NIW petition on April 10, 2025, less than a year after filing on May 29, 2024. This success not only affirms the strength of the petition but also underscores the importance of impactful scientific research in immigration pathways.
We are proud to contribute to the success of researchers like this client, whose work carries profound implications for public health and scientific advancement. His story is a testament to what thoughtful strategy, rigorous documentation, and expert advocacy can accomplish.